PM
AGL icon

Prosight Management’s Agilon Health AGL Stock Holding History

Prosight Management’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,163
Closed -$1.4M – 35
2023
Q3 		$1.4M Sell
3,163
-837
-21% -$378K 0.45% 35
2023
Q2 		$1.73M Buy
+4,000
New +$2.25M 0.51% 31
2022
Q2 		– Sell
-5,600
Closed -$3.55M – 25
2022
Q1 		$3.55M Sell
5,600
-400
-7% -$206K 2.29% 13
2021
Q4 		$4.05M Buy
6,000
+1,620
+37% +$986K 2.42% 16
2021
Q3 		$2.87M Buy
+4,380
New +$3.74M 1.58% 23

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Prosight Management's AGL Position: Q4 2023 in Review

Prosight Management sold out of Agilon Health (AGL) in Q4 2023, closing a stake of 3,163 shares — an estimated $1.4M sold.

Prosight Management first reported a position in AGL in Q3 2021 and held it in 5 quarters. The position peaked at $4.05M in Q4 2021. 193 funds tracked by Wall St. Rank hold AGL as of Q4 2023.

  • Prosight Management reported no remaining Agilon Health position as of Q4 2023 after selling out during the quarter.
  • Prosight Management sold 3,163 Agilon Health shares in Q4 2023, an estimated $1.4M.
  • Prosight Management first reported a position in Agilon Health in Q3 2021 and held it in 5 quarters.
  • Prosight Management's Agilon Health position peaked at $4.05M in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Agilon Health as of Q4 2023.

Based on Prosight Management's 13F filing for Q4 2023, filed 14 Feb 2024.